SOAP star Adam Thomas has shared a new health update in his crippling battle with arthritis. The 37-year-old is suffering ...

A former Strictly Come Dancing star has revealed a 'big wake up call' when they woke up in 'severe pain'. Adam Thomas, known ...

Adam Thomas has said he has suffered a 'wake-up call' after what he called becoming 'complacent' after seemingly getting a ...

Alum Dinesh Patel developing blockbuster new drug treatments gives back to Rutgers to support its chemistry lab ...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 23 scientific posters at Maui Derm Hawaii 2026 (Jan. 25-29), showcasing a comprehensive body of evidence across ...

Chronic venous insufficiency can develop at any age, but as we get older, the risk increases. Here's what you need to know.

The phase 3b TOGETHER-PsA trial evaluated the safety and efficacy of concomitant ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.

Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...

Small changes that make all the difference ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers Squibb face similar patent cliffs.

CivicaScript recently announced the availability of two new products: insulin glargine-yfgn and ustekinumab-aauz.